Who is sponsoring NCT05044767?

NCT05044767 is sponsored by ATF Implants.

What drugs are being tested in NCT05044767?

Interventions in NCT05044767: total hip arthroplasty.

What condition does NCT05044767 study?

NCT05044767 studies Arthroplasty, Hip, Replacement.

Is NCT05044767 still recruiting?

NCT05044767 is currently recruiting now. Last updated 1 February 2023.

Last reviewed 2023-02-01 · How we verify

NCT05044767

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study to Evaluate the Performance and Safety of ATF Implants and Lapé Médical Devices Implanted During Hip Arthroplasty

Recruiting now Last updated 1 February 2023

What this trial tests

trial testing total hip arthroplasty in Arthroplasty, Hip, Replacement in 4,500 participants. Currently enrolling.

Timeline

7 June 2021

Primary endpoint
31 December 2032

31 December 2032

Quick facts

Lead sponsor	ATF Implants
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	4,500
Start date	7 June 2021
Primary completion	31 December 2032
Estimated completion	31 December 2032
Sites	13 locations across France

Drugs / interventions tested

total hip arthroplasty

Conditions studied

Arthroplasty, Hip, Replacement — all drugs for Arthroplasty, Hip, Replacement →

Sponsor

ATF Implants

Who can join

Eligibility, any sex, with Arthroplasty, Hip, Replacement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Observational and prospective multicenter study to evaluate the long-term (10 years) performance and safety (10 years) of ATF Implants and Lapé Médical devices implanted during total hip arthroplasty or hemiarthroplasty.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of total hip arthroplasty

Trials testing the same drug.

NCT06176612 — In Patients With Hip Dysplasia, Mid-Term Lower Extremities and Spine After Hip Arthroplasty Natural Course · NA · completed
NCT03492684 — Superior Gluteal Neuropathy -Total Hip Arthroplasty · unknown
NCT04199390 — Physical Therapy Following Total Hip Arthroplasty · NA · completed
NCT03428672 — Quantitative Analysis of Global Proteome in Bone Samples From Patients With Osteoporotic and Nonosteoporotic Fracture · NA · unknown
NCT06360835 — Our Experience in the Management of Therapeutic Failures of Fractures of the Proximal End of the Femur (About 35 Cases) · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05044767 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by ATF Implants
Last refreshed: 1 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05044767.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing